Cold protein shakes, Greek yogurt, cottage cheese, cold chicken, applesauce, bananas, plain crackers, and ginger tea are all well tolerated options
Neither is currently covered by the HSE or the Drugs Payment Scheme for weight management, though reimbursement assessments are ongoing via NCPE
Current and Pipeline GLP-1 Agonists Following the 2005 approval of exenatide for Type 2 Diabetes, there have been a series of approvals for GLP-1 agonists in both diabetes and obesity
Relative contraindications requiring caution include active or suspected cancer (GHK-Cu promotes angiogenesis with concern about theoretically feeding tumors, though conflicting data shows documented anti-cancer gene expression effects requiring medical supervision), severe organ dysfunction (kidney or liver failure may slow peptide clearance), hemochromatosis or copper overload conditions, autoimmune disorders, and patients on immunosuppressants or blood thinners